News Theresa May backtracks on 'Dementia tax' Parties take out rival ads as social care funding row escalates.
News Mixed data mar Sanofi's venglustat programme Sanofi has reported positive phase 3 results with venglustat in Gauder disease, but the drug missed the mark in a Fabry disease trial.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.